Malignant pleural mesothelioma (MPM) is an aggressive cancer most commonly caused by
prior exposure to asbestos. Median survival is 12–18 months, since surgery is ineffective …

Introduction: Malignant pleural mesothelioma (MPM) has limited treatment options with
minimal new therapy approvals for unresectable disease in the past 15 years. However …

Background Asbestos lung content is regarded as the most reliable tool for causal attribution
of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack …

Simple Summary Asbestos consumption figures could be used to construct epidemiological
models to forecast the pleural mesothelioma mortality, although they are not frequently taken …

Asbestos (all forms, including chrysotile, crocidolite, amosite, tremolite, actinolite, and
anthophyllite) is carcinogenic to humans and causally associated with mesothelioma and …

Background In Italy the incidence of malignant mesothelioma (MM) among women is
remarkably high, due to the several contexts in which women had been exposed to …

Background Asbestos is a known human carcinogen and is causally associated with
malignant mesothelioma, lung, larynx and ovarian cancers. Methods Cancer risk was …

Objectives Workers in the construction industry have been exposed to asbestos in various
occupations. In Italy, a National Mesothelioma Registry has been implemented more than 20 …

Exposure to asbestos causes a wide range of diseases, such as asbestosis, malignant
mesothelioma (MM) and other types of cancer. Many European countries have reduced …

Despite their differences, pleural and peritoneal mesothelioma are frequently lumped
together to describe epidemic curves and to forecast future mesothelioma trends. This study …